Skip to content

A verification study of improvement effects on bowel movement

A verification study of improvement effects on bowel movement: a randomized, placebo-controlled, double-blind, parallel-group comparison study - A verification study of improvement effects on bowel movement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057165
Enrollment
20
Registered
2025-02-28
Start date
2025-02-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese

Interventions

Duration: Two weeks Test food: Test food A Duration: Two weeks Test food: Test food B

Sponsors

Central Research Institute, ITO EN, LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Japanese 2. Men or women 3. Adults 4. Healthy individuals 5. Individuals whose defecation frequency is three to five times per week in Period 1 6. Individuals whose defecation frequency is three to five times per week in Period 2

Exclusion criteria

Exclusion criteria: 1. Individuals who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 2. Individuals who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Individuals who are currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Individuals who are taking "Foods for Specified Health Uses" or "Foods with Functional Claims" 5. Individuals who are taking or using medications (including herbal medicines) or supplements 6. Individuals who are allergic to medicines or foods related to the test product, particularly those with allergies to burdock, barley, or wheat 7. Individuals who regularly take grapes, wine, grape juice, or polyphenol-rich foods or beverages (such as cacao, citrus fruits, or black tea) 8. Individuals who are pregnant, lactating, or planning to become pregnant during this study 9. Individuals who have been enrolled in other clinical studies within the last 28 days before the agreement to participate in this study or plan to participate in another study during this study 10. Individuals who are judged as ineligible to participate in this study by the physician

Design outcomes

Primary

MeasureTime frame
1. The measured value of defecation frequency in period 4* *Period 4: 8~14 days after intervention

Secondary

MeasureTime frame
1. The change from period 2* of defecation frequency in period 4 2. The measured value and change from period 2 of defecation frequency in period 3* 3. The measured value and the change from period 1*-2 of defecation frequency in period 3-4 4. The measured values and changes from period 2 of numbers of defecation days and amount of defecation in period 3 and 4 5. The measured values and changes from period 1-2 of numbers of defecation days and amount of defecation in period 3-4 6. Individuals whose stool shape, stool smell, and exhilarating feeling of defecation improved by one or more scales in period 3 compared to period 2 7. Individuals whose stool shape, stool smell, and exhilarating feeling of defecation improved by one or more scales in period 4 compared to period 2 8. Individuals whose stool shape, stool smell, and exhilarating feeling of defecation improved by one or more scales in period 3-4 compared to period 1-2 9. The measured value and change from screening (before intervention; Scr) of the Constipation Assessment Scale (CAS) score in the CAS Middle Term version (CAS-MT) at two weeks after intervention (2w) 10. Individuals whose response to an original questionnaire improved by one or more scales at 2w compared to Scr *Period 1: 14~8 days before Scr Period 2: 7 days before Scr Period 3: For 7 days since the first intervention

Countries

Japan

Contacts

Public ContactNaoko Suzuki

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026